These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37817262)

  • 21. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
    Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Importance of the Lymph Node Factor in Surgically Resected Non-Small Cell Lung Cancer.
    Tezel C; Dogruyol T; Alpay L; Akyıl M; Evman S; Metin S; Baysungur V; Yalcinkaya I
    Thorac Cardiovasc Surg; 2020 Mar; 68(2):183-189. PubMed ID: 30388719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
    Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node metastasis outside of a tumor-bearing lobe in primary lung cancer and the status of interlobar fissures: The necessity for removing lymph nodes from an adjacent lobe.
    Li H; Wang R; Zhang D; Zhang Y; Li W; Zhang B; Liu Q; Du J
    Medicine (Baltimore); 2019 Mar; 98(12):e14800. PubMed ID: 30896623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrapulmonary lymph node (stations 13 and 14) metastasis in peripheral non-small cell lung cancer.
    Bi L; Zhang H; Ge M; Lv Z; Deng Y; Rong T; Liu C
    Medicine (Baltimore); 2021 Jul; 100(27):e26528. PubMed ID: 34232188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Prognostic Significance of Metastasis to Lymph Nodes in Aortopulmonary Zone (Stations 5 and 6) in Completely Resected Left Upper Lobe Tumors.
    Citak N; Sayar A; Metin M; Büyükkale S; Kök A; Solak O; Yurt S; Gürses A
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):568-76. PubMed ID: 25893919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of plasma D-dimer levels for predicting lymph node and mediastinal lymph node involvement in non-small cell lung cancer.
    Gao XL; Wang SS; Cao DB; Liu W
    Clin Respir J; 2018 Jun; 12(6):2151-2156. PubMed ID: 29498801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impact of node involvement pattern in pN1 non-small cell lung cancer patients.
    Nakao M; Yoshida J; Ishii G; Kawase A; Maeda R; Aokage K; Hishida T; Nishimura M; Nagai K
    J Thorac Oncol; 2010 Oct; 5(10):1576-82. PubMed ID: 20802346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.
    Maeshima AM; Tsuta K; Asamura H; Tsuda H
    Cancer; 2012 Sep; 118(18):4512-8. PubMed ID: 22282325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of node involvement pattern in pulmonary pN1 squamous cell carcinoma patients.
    Nakao M; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    J Thorac Oncol; 2010 Apr; 5(4):504-9. PubMed ID: 20104192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer.
    Lee GD; Kim DK; Moon DH; Joo S; Hwang SK; Choi SH; Kim HR; Kim YH; Park SI
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):580-8. PubMed ID: 25890940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.
    Gajra A; Newman N; Gamble GP; Kohman LJ; Graziano SL
    J Clin Oncol; 2003 Mar; 21(6):1029-34. PubMed ID: 12637467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.
    Sawyer TE; Bonner JA; Gould PM; Foote RL; Deschamps C; Trastek VF; Pairolero PC; Allen MS; Shaw EG; Marks RS; Frytak S; Lange CM; Li H
    Cancer; 1997 Oct; 80(8):1399-408. PubMed ID: 9338463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study.
    Adachi H; Sakamaki K; Nishii T; Yamamoto T; Nagashima T; Ishikawa Y; Ando K; Yamanaka K; Watanabe K; Kumakiri Y; Tsuboi M; Maehara T; Nakayama H; Masuda M
    J Thorac Oncol; 2017 Jan; 12(1):85-93. PubMed ID: 27553515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.
    Shi CL; Zhang XY; Han BH; He WZ; Shen J; Chu TQ
    Med Oncol; 2011 Dec; 28(4):1441-6. PubMed ID: 20661664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What do we need to care about doing lymph-node dissection for the early-staged non-small cell lung cancer?
    Zhang C; Xu S; Liu Y
    Asian J Surg; 2022 Nov; 45(11):2435-2436. PubMed ID: 35667927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.